The risks of using allogeneic cell lines for vaccine production: the example of Bovine Neonatal Pancytopenia
Introduction: Bovine neonatal pancytopenia (BNP) is a hemorrhagic disease that emerged in calves across Europe in 2007. Its occurrence is attributed to immunization of the calf’s mother with a vaccine produced using an allogeneic cell line. Vaccine-induced alloantibodies specific for major-histocomp...
Main Authors: | Lindert Benedictus, Charlotte R. Bell |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2017.1249859 |
Similar Items
-
Three cases of alloimmune mediated pancytopenia in calves resembling bovine neonatal pancytopenia
by: L. Chantillon, et al.
Published: (2022-01-01) -
Red blood cell alloimmunization in Iran: A Comprehensive review of the literature
by: Maryam Sadat Hosseini, et al.
Published: (2020-01-01) -
Red cell alloimmunization in multi-transfused, oncology patients: Risks and management
by: Sadhana Mangwana, et al.
Published: (2019-01-01) -
Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report
by: Minhazur Sarker, et al.
Published: (2022-07-01) -
Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Nataliya Prokopenko Buxbaum, et al.
Published: (2020-08-01)